Medroxyprogesterone comment watch save

  • TRADE NAMES: Alti-MPA; Aragest 5; Clinofem; Depo-Provera (Pfizer); Gestapuran; Lunelle (Pfizer); Novo-Medrone; Perlutex; Premphase (Wyeth); Prempro (Wyeth); Progevera; Provera (Pfizer); Ralovera
  • INDICATIONS: Secondary amenorrhea, renal or endometrial carcinoma
  • CLASS: Progestogen
  • HALF-LIFE: 30 days

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top